Antiangiogenic Agents and HIF-1 Inhibitors Meet at the Crossroads

Cell Cycle - United States
doi 10.4161/cc.8.24.10145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

At the Crossroads of Cancer and Inflammation: Ras Rewires an HIF-driven IL-1 Autocrine Loop

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2010English

At the Crossroads of Oxygen and Iron Sensing: Hepcidin Control of HIF-2α

Journal of Clinical Investigation
Medicine
2018English

Effects of Histone Deacetylase Inhibitors on HIF-1

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2006English

Antiangiogenic Agents in Cancer Therapy

Journal of the Royal Society of Medicine
Medicine
1999English

Natural Product-Based Inhibitors of Hypoxia-Inducible Factor-1 (HIF-1)

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2006English

At the Crossroads

MTZ industrial
2017English

At the Crossroads

Journal of the Air Pollution Control Association
1984English

At the Crossroads

2009English

The Beclin 1–VPS34 Complex – At the Crossroads of Autophagy and Beyond

Trends in Cell Biology
Cell Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy